BARRIERS IN HERBAL DRUGS CLINICAL TRIAL

About This Presentation
Title:

BARRIERS IN HERBAL DRUGS CLINICAL TRIAL

Description:

More than any other traditional or alternative medicine strategy, herbal medicines are closest to the conventional treatment method. Herbal remedies have been divided into four categories based on their origin, evolution, and contemporary forms of use, including indigenous herbal remedies; herbal remedies used in systems (AYUSH), modified herbal remedies, and imported goods with herbal medicine base. Herbal medications are dispensed or supplied mostly by pharmacists and are prescribed by doctors all over the world as adjuvant or adjuncts with contemporary drugs. See More : – PowerPoint PPT presentation

Number of Views:0
Slides: 10
Provided by: herbcyte

less

Transcript and Presenter's Notes

Title: BARRIERS IN HERBAL DRUGS CLINICAL TRIAL


1
BARRIERS IN HERBAL DRUGS CLINICAL TRIAL
2
Overview
More than any other traditional or alternative
medicine strategy, herbal medicines are closest
to the conventional treatment method. Herbal
remedies have been divided into four categories
based on their origin, evolution, and
contemporary forms of use, including indigenous
herbal remedies herbal remedies used in systems
(AYUSH), modified herbal remedies, and imported
goods with herbal medicine base. Herbal
medications are dispensed or supplied mostly by
pharmacists and are prescribed by doctors all
over the world as adjuvant or adjuncts with
contemporary drugs. Only the USA has laws that
classify herbs as dietary supplements and have
removed them from the medical prospect among
developed nations.
3
A Requirement for Clinical Research on Herbal
Drugs
  • All around the world, herbal products have grown
    to be a crucial and essential component of public
    healthcare. A number of studies on conventional
    and complementary medicine have revealed their
    pervasive use. However, clinical trials of these
    herbal products ought to be promoted in order to
    broaden their audience of acceptance.
  • Use of single, dependable batches of
    formulations is advocated to demonstrate efficacy
    in clinical studies. Although many who use and
    believe in herbs do not need clinical studies, it
    is now necessary for their widespread acceptance
    and survival on the global market alongside
    modern pharmaceuticals.

4
The Difficulties of Conducting Clinical Research
on Herbal Drugs
  • All around the world, herbal products have grown
    to be a crucial and essential component of public
    healthcare. A number of studies on conventional
    and complementary medicine have revealed their
    pervasive use. However, clinical trials of these
    herbal products ought to be promoted in order to
    broaden their audience of acceptance.
  • Use of single, dependable batches of
    formulations is advocated to demonstrate efficacy
    in clinical studies. Although many who use and
    believe in herbs do not need clinical studies, it
    is now necessary for their widespread acceptance
    and survival on the global market alongside
    modern pharmaceuticals.

5
The Difficulties of Conducting Clinical Research
on Herbal Drugs
There are a number of obstacles to research on
herbal medicines that must be overcome. These
include concerns including those pertaining to
the financial, moral, product standardization,
study design, and regulatory requirements before
to registering an experimental new medication for
the purpose of carrying out sizable phase III
trials. The WHO developed operational guidelines
that provide information on how to conduct
clinical trials with herbal products it has been
argued that the inclusion criteria might be based
either on current medical diagnosis or on the
diagnostic of herbal.
6
Blinding is a gold standard in randomized
clinical trials (RCT)
  • The choice of controls presents a further
    difficulty in the RCT of herbal medications. As
    comparison similarity is crucial if the trial is
    meant to give evidence of a specific impact of
    the herbal medication, controls are chosen so
    that they closely resemble the intervention
    group.
  • Controls for elements including colour, odour,
    duration, frequency of intake, believability of
    the treatment to the patient, and the physical
    environment in which treatments are provided,
    should be standardized.

7
Blinding is a gold standard in randomized
clinical trials (RCT)
  • It is now understood that occupational
    standardization must continue. This is especially
    obvious in herbal product studies where the
    therapist actively participates. The protocol may
    make the practitioners feel uneasy since they
    want to offer the finest therapeutic care
    possible, which could lead to protocol
    violations.
  • By offering treatment manuals outlining the
    particular steps to be taken, this therapist
    variability can be decreased.

8
Blinding is a gold standard in randomized
clinical trials (RCT)
  • Herbal medication has a unique approach and
    might not be standardized as a population-wide
    treatment.  Furthermore, the outcomes of trials
    may be influenced by the strong faith and
    confidence. It is necessary to conduct baseline
    evaluations of a variety of psychological
    variables, including mood and personality.
  • The issue sample contamination is another matter
    of concern. The researchers should closely watch
    their trial participants to discover whether they
    look for herbal products outside of the
    established protocol. Above mentioned trial
    conduction practice to be supports in the herbal
    clinical research for overcome the issue arises
    during trial.

9
Reach Us To Get More Details
Email herbcyte_at_gmail.com Phone
919962417611 Web herbcyte.com
Write a Comment
User Comments (0)